Does desloratadine alter the serum levels of montelukast when administered in a fixed-dose combination?-Reference-Cited by-同舟云学术

Does desloratadine alter the serum levels of montelukast when administered in a fixed-dose combination?

Published:2013-08-05 Issue:11 Volume:123 Page:2610-2614
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Cingi Cemal¹,Toros Sema Zer²,Ince Iskender³,Ertugay Cigdem Kalaycik⁴,Gurbuz M. Kezban¹,Cakli Hamdi¹,Erdogmus Nagehan¹,Karasulu Ercument¹³,Kaya Ercan¹³

Affiliation:

1. Medical Faculty, Department of Otorhinolaryngology; Osmangazi University; Eskisehir Turkey

2. Department of Otorhinolaryngology/Head and Neck Surgery; Haydarpasa Numune Research and Education Hospital; Istanbul Turkey

3. Center for Drug Research and Development and Pharmacokinetic Applications; Ege University; Izmir Turkey

4. Department of Otorhinolaryngology/Head and Neck Surgery; Tokat State Hospital; Tokat Turkey

Publisher

Wiley

Subject

Otorhinolaryngology

Reference25 articles.

1. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine;Ciebiada;J Investig Allergol Clin Immunol,2008

2. Allergic rhinitis and its impact on asthma;Bousquet;J Allergy Clin Immunol,2001

3. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study;Nettis;Clin Exp Allergy,2004

4. Montelukast in the treatment of allergic rhinitis: an evidence-based review;Nayak;Drugs,2007

5. Modern H1-antihistamines in asthma;Borade;Drug Discov Today Ther Strateg,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Turkish Guidelines for Diagnosis and Treatment of Allergic Rhinitis (ART);Turkish Archives of Otorhinolaryngology;2021-05-01

2. Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor;Drug Metabolism and Disposition;2015-07-01

3. A Long-Standing Mystery Solved: The Formation of 3-Hydroxydesloratadine Is Catalyzed by CYP2C8 But Prior Glucuronidation of Desloratadine by UDP-Glucuronosyltransferase 2B10 Is an Obligatory Requirement;Drug Metabolism and Disposition;2015-01-16